Ratings Summary for COMPAZINE

Overall Patient opinion of COMPAZINE: 1.2 (extremely dissatisfied)

(based on 504 reviews ) (updated May 6, 2025)

Ratings by Age Group for COMPAZINE
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group	Number of Reviews	Average Rating
Pediatric (Under 18)	33	1.3
Age 18 to 24	103	1.2
Age 25 to 34	158	1.2
Age 35 to 44	127	1.2
Age 45 to 54	51	1.4
Age 55 to 64	18	1.7
Age 65 to 74	2	1
Age 75 and up	1	5

Ratings by Sex for COMPAZINE
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex	Number of Reviews	Average Rating
Male	86	1.37209302325581
Female	408	1.27205882352941
Not Specified	8	1.5

Would you like to find reviews for COMPAZINE taken for a specific reason or resulting in a specific side effect?

Filter Results for COMPAZINE

Patient Type:	Any Male Female
Reason(s):
Side Effect(s):
Satisfaction:	1 2 3 4 5

FDA Drug Safety Information for COMPAZINE

Check here for Ask a Patient's Adverse Event Summary for COMPAZINE based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.

COMPAZINE (PROCHLORPERAZINE MALEATE): This medication is used to treat severe nausea and vomiting from certain causes (for example, after surgery or cancer treatment). Prochlorperazine belongs to a class of drugs known as phenothiazines. This medication is not recommended for use in children younger than 2 years or in children going through surgery. FDA Approval Date: (Sources: U.S. Centers for Medicare Services, FDA)